Skip to main content

Table 3 Analysis of MIDAS and HIT score in a different group (A: Sodium Valproate; B: Sodium Valproate +Magnesium; C: Magnesium) compared to baseline

From: Comparative study of magnesium, sodium valproate, and concurrent magnesium-sodium valproate therapy in the prevention of migraine headaches: a randomized controlled double-blind trial

 

A

P-value

B

P-value

C

P-value

Pre-intervention

Post-intervention

 

Pre-intervention

Post-intervention

 

Pre-intervention

Post-intervention

 

MIDAS

21.74 ± 4.44

17.11 ± 4.06

< 0.001

21.68 ± 3.72

16.11 ± 3.87

< 0.001

22.13 ± 1.88

18.81 ± 1.76

< 0.001

HIT-6

56.72 ± 4.59

49.91 ± 4.58

< 0.001

56.89 ± 3.84

50.50 ± 3.27

< 0.001

57.54 ± 2.13

53.03 ± 1.88

< 0.001

  1. MIDAS migraine disability assessment score; HIT-6 Headache Impact Test-6 score